Industry majors would have taken notice as soon as phase 1 was complete and ticked all the boxes. My belief about the current share price and lack of on market interest is due to inaction. If CYP has what we all think, where is the interest? Shareholder and industry? Is there hesitation due to lack of director confidence, are others waiting on Fuji, or has management just one hook? Where is the update? Where is the report? Where is cellularity? where is asthma?
Regulators and allogeneic off the shelf, page-11
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.005(1.82%) |
Mkt cap ! $50.58M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 26.5¢ | $71.17K | 257.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 145786 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |